(Rac) -ErSO-DFP
(Rac) -ErSO-DFP is a selective ERα biomodulator that exhibits potent anti-tumor activity against ERα-positive breast cancers, including therapy-resistant forms. It functions by hyperactivating the anticipatory unfolded protein response (a-UPR) pathway, leading to rapid tumor cell death. This mechanism has been validated in both in vitro cell studies and in vivo xenograft models, highlighting its research utility in oncology and cancer pharmacology.
Product Specifications
CAS Number
2768139-73-5
Field of Research
Metabolism Research, Signal Transduction
Smiles
O=C1C (C=2C (N1) =C (C (F) (F) F) C=CC2) (N3CCC (F) (F) CC3) C4=CC=C (O) C=C4
Molecular Formula
C20H17F5N2O2
Molecular Weight
412.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
